C19-YRS Items

Total (n = 413)

P-value

Symptoms in the acute phase

(Less than 28 days)

Persistence symptoms

(More than 28 days)

Body Function and Structure

Breathlessness (%)

31.6%

12.5%

At rest (M, SD)

1.8 (2.9)

0.1 (0.3)

0.77

Dressing (M, SD)

1.6 (2.8)

0.3 (0.8)

0.20

Stairs (M, SD)

2.0 (3.1)

0.4 (1.0)

0.20

laryngeal complication (%)

11.5%

50%

(M, SD)

0.3 (1.1)

1.2 (1.5)

0.01

voice changes (%)

5.4%

0

(M, SD)

0.2 (0.8)

0.0 (0)

0.63

Swallowing changes (%)

10%

43.8%

(M, SD)

0.3 (1.0)

1.5 (1.9)

0.00

Loss of appetite (%)

14.8%

18.8%

(M, SD)

0.6 (1.6)

1.1 (2.7)

0.27

Fatigue (%)

27.1%

31.3%

(M, SD)

0.9 (1.9)

0.9 (1.4)

0.46

Pain/discomfort (%)

12%

18.8%

(M, SD)

0.5 (1.5)

0.7 (1.7)

0.65

Anxiety (%)

13.3%

0

(M, SD)

0.6 (1.8)

0.0 (0.0)

0.31

Depression (%)

13%

6.3%

(M, SD)

0.6 (1.9)

0.1 (0.5)

0.45

Bladder continence (%)

0.8%

0

(M, SD)

0.01 (0.1)

0.0 (0.0)

0.91

Activities

Mobility (%)

11%

18.8%

(M, SD)

0.5 (1.5)

0.4 (0.8)

0.72

Personal care (%)

2%

0

(M, SD)

0.1 (0.4)

0.0 (0.0)

0.83

Usual activities (%)

11.5%

0

(M, SD)

0.4 (1.3)

0.0 (0.0)

0.34

Personal factor

Global Health (%)

391

16

(M, SD)

8.6 (1.8)

8.6 (1.3)

0.35